Insider Buying: CapsoVision (NASDAQ:CV) Major Shareholder Purchases $495,117.00 in Stock

CapsoVision, Inc. (NASDAQ:CV) major shareholder Eliyahou Et Al Harari purchased 81,300 shares of the firm’s stock in a transaction that occurred on Wednesday, July 8th. The stock was bought at an average cost of $6.09 per share, for a total transaction of $495,117.00. Following the purchase, the insider owned 3,282,051 shares in the company, valued at $19,987,690.59. This represents a 2.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Eliyahou Et Al Harari also recently made the following trade(s):

• On Friday, June 26th, Eliyahou Et Al Harari purchased 13,850 shares of CapsoVision stock. The stock was bought at an average price of $7.35 per share, for a total transaction of $101,797.50.

CapsoVision Price Performance

CapsoVision stock opened at $5.99 on Monday. The firm has a market capitalization of $299.26 million and a P/E ratio of -2.56. The stock has a fifty day moving average price of $6.87 and a two-hundred day moving average price of $6.66. CapsoVision, Inc. has a 52-week low of $3.43 and a 52-week high of $15.37.

CapsoVision (NASDAQ:CV) last issued its earnings results on Thursday, May 14th. The company reported ($0.15) EPS for the quarter. The firm had revenue of $2.79 million for the quarter.

Institutional Trading of CapsoVision

Several large investors have recently made changes to their positions in the business. State Street Corp raised its holdings in shares of CapsoVision by 340.7% in the fourth quarter. State Street Corp now owns 85,929 shares of the company’s stock valued at $919,000 after buying an additional 66,429 shares during the last quarter. Bank of New York Mellon Corp acquired a new stake in CapsoVision in the 1st quarter valued at about $359,000. Geode Capital Management LLC increased its position in CapsoVision by 34.1% in the 4th quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock valued at $1,649,000 after acquiring an additional 39,231 shares in the last quarter. Citadel Advisors LLC bought a new position in shares of CapsoVision in the third quarter worth about $115,000. Finally, Bank of America Corp DE lifted its position in shares of CapsoVision by 528.9% during the first quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock worth $162,000 after purchasing an additional 18,702 shares in the last quarter.

Analysts Set New Price Targets

A number of equities analysts have commented on CV shares. Weiss Ratings restated a “sell (d-)” rating on shares of CapsoVision in a research report on Monday, June 29th. Benchmark dropped their price objective on shares of CapsoVision from $14.00 to $10.00 and set a “speculative buy” rating for the company in a report on Friday, March 27th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $8.50.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.